BACKGROUND. Patients with terminal malignant disease commonly report hyposa
livation or xerostomia. This leads to "dry mouth," fungal infection, and mu
cosal abnormalities. To the authors' knowledge oral symptomatology and find
ings have not been correlated previously with accurate salivary flow measur
ements.
METHODS. Measurement of stimulated parotid salivary now rate and clinical r
ecording of oral symptoms within 24 hours from the time of hospital admissi
on were obtained in 48 terminally ill cancer patients. Subjective reporting
of symptoms by patients, parotid salivary flow rate, clinical recording of
dental status, presence of candidiasis, angular cheilitis, and dryness of
the floor of the mouth were obtained.
RESULTS. A clinical diagnosis of oral candidiasis was made tentatively in 9
4% of patients, and 50% of the patients were found to have angular cheiliti
s. Thirty-one of 45 evaluable patients (68%) reported a sensation of oral d
ryness. Sixteen of the 48 patients (33%) had no saliva at the floor of the
mouth. Analysis of individual salivary flow rates was stratified into 3 lev
els of secretion: 0, < 0.2, and greater than or equal to 0.2 mL/minute. Sym
ptoms were found to correlate with salivary flow rates.
CONCLUSIONS, In the current study, symptoms were found to be most severe in
the patients with xerostomia followed by those patients with hyposalivatio
n. Treatment should be directed individually to each group of patients usin
g either salivary substitutes or stimulants. The rate of incidence of oral
pathologic findings may be higher than formerly recognized. (C) 2000 Americ
an Cancer Society.